Scientists test drug Mix-Ups for future MS therapy
NCT ID NCT06064539
Summary
This early-stage study checked how two common medications (gemfibrozil and rifampicin) affect the way the body processes an experimental drug for multiple sclerosis (SAR442168). It involved 30 healthy male volunteers to measure drug levels and safety. The goal was to understand potential interactions before testing the MS drug in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Prism Research-Site Number:8400001
Saint Paul, Minnesota, 55144, United States
Conditions
Explore the condition pages connected to this study.